NCM · Medical - Specialties

ITOC (ITOC) Stock

$0.25 +0.56% NCM: ITOC Healthcare

Valuation

MetricValue
Price$0.25
Market Cap$2.35M
P/E Ratio-6.40
P/B Ratio0.88
P/S Ratio9.87
EPS (TTM)$-0.05
52-Week High$32.00
52-Week Low$0.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-71.25%
ROA-40.98%
ROCE-16.67%
Gross Margin82.86%
Operating Margin-831.07%
Net Margin-790.57%
Debt/Equity0.03
Current Ratio7.00

Annual Financials (USD)

Metric2021202220232024
Revenue$1.0M$1.0M$1.0M$0
Operating Profit$0$0$0$-1.0M
Net Profit$0$0$0$-1.0M
EPS$0.01$0.01$-0.02$-0.05
Op Margin19.6%4.0%-48.8%-171.9%

Balance Sheet (USD)

Metric2021202220232024
Total Assets$1.0M$1.0M$2.0M$7.0M
Total Liabilities$0$1.0M$1.0M$1.0M
Cash$0$0$0$6.0M
Borrowings$0$0$0$0

Latest News

iTonic Holdings Ltd Issues an Update on its Effort to Develop AI-Powered Cloud Healthcare Platform Designed to Support Nuclear Medicine Treatment Planning and with Potential Future Expansion into Digital Care Delivery GlobeNewswire · Jul 15, 2026 Top Premarket Decliners MT Newswires · Jun 9, 2026

Cash Flow (USD)

Metric2021202220232024
Operating Cash Flow$0$0$0$-1.0M
Investing Cash Flow$0$0$0$0
Financing Cash Flow$0$0$0$-1.0M
Net Cash Flow$0$0$0$6.0M
Free Cash Flow$0$0$0$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-94.24%
Quick Ratio11.36
Interest Coverage—
Return 1Y-98.45%
Return 3Y—
Return 5Y—

Ownership

Insiders Held1.82%
Institutions Held0.10%
Institutions Float Held0.11%
Institutional HolderSharesReport Date
Xtx Topco Ltd48,3252026-03-31
Citadel Advisors Llc29,5532026-03-31
Point72 Asset Management, L.P.10,8522026-03-31
Cygnus Capital Advisors, LLC5,2482026-03-31
National Bank of Canada/FI/1,8002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About ITOC

ITOC is led by CEO Jianfei Zhang, publicly traded since 2024.

ITOC stock trades at $0.25 with a market capitalization of $2.35M. The stock is valued at a price-to-earnings (P/E) ratio of -6.40, price-to-book of 0.88, price-to-sales of 9.87. Over the past 52 weeks the stock has ranged between $0.25 and $32.00, and currently trades 99.2% below its 52-week high.

On profitability, ITOC generates a return on equity (ROE) of -71.25%, return on capital employed of -16.67%, an operating margin of -831.07%, a net profit margin of -790.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides